This is a preview of subscription content, log in via an institution to check access.
Notes
EGFR mutation and ALK IHC testing, followed by ALK FISH confirmation in IHC-positive patients
2013 US dollars
Reference
Romanus D, et al. Cost-Effectiveness of Multiplexed Predictive Biomarker Screening in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : 14 Jan 2015. Available from: URL: http://doi.org/10.1097/JTO.0000000000000474
Rights and permissions
About this article
Cite this article
Predictive biomarker screening cost effective for NSCLC. PharmacoEcon Outcomes News 720, 27 (2015). https://doi.org/10.1007/s40274-015-1866-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1866-7